Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Can now perform extractables and leachables testing at Shanghai Facility
June 14, 2017
By: Tim Wright
Editor-in-Chief, Contract Pharma
SGS has increased its capabilities to undertake extractables and leachables (E&L) testing at its Shanghai, China, laboratory with an investment that includes the installation of multiple analytical instruments, including an isothermal static headspace gas chromatograph with flame ionization detector (HS-GC/MS-FID), two liquid chromatography–mass spectrometers (LC-MS) and one system. A liquid chromatography with time of flight mass spectrometer (LC-TOF-MS) has also been acquired, along with two inductively coupled plasma mass spectrometers (ICP-MS) and one inductively coupled plasma optical emission spectrometer (ICP-OES). All instruments have undergone installation and validation and are fully 21 CFR part 11 compliant to ensure integrity of information for regulatory submissions. In June 2016, SGS announced that it had expanded the laboratory in Shanghai and invested in instruments to undertake comprehensive drug compatibility study testing at the facility and to evaluate E&L contamination. This additional investment allows SGS to increase its capacity to handle E&L projects for applications including container testing, medical device evaluation and testing equipment used in pharmaceutical production. “Extractables and leachables testing continues to be a much sought after service by the pharmaceutical industry, and SGS is renowned around the world for its expertise and experience in this area,” said Andy Yi, general manager, SGS Life Sciences, China. “This continued investment in the facilities in Shanghai doubles our capacity in the E&L field, and is in response to the rapid increase in demand from our clients, for whom regulatory compliance is paramount and who trust SGS to overcome analytical challenges effectively and efficiently.” The investment in Shanghai is the latest undertaken by SGS in E&L testing capabilities, which has also seen the opening of a new global Center of Excellence for Extractable Studies and Impurities Profiling in Wiesbaden, Germany, and the expansion of services offered at its Fairfield, NJ, laboratory.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !